Value Microcaps Zip Code Changers

[Bobwins]

ATE.v/ATBPF -.02 to C$.47 well Antibe didn't hold so glad I at least sold 1/2 in the C$.60's. New report from Zack's give new price target of C$1.80 based on the successful phase II test.

http://scr.zacks.com/News/Press-Releases/Press-Release-Details/2018/ATEV-Positive-Results-from-Phase-2b-Trial-of-ATB-346/default.aspx

Holding for regional licensing agreements but mainly for a Big Pharma to take ATB-346 thru phase III trials to commercialization. Such an agreement would include milestone payments to keep Antibe fundraising to a minimum and ~12% royalty payments on commercial sales.

But it ain't here yet so have to wait a few more months. Trying to nibble on a few shares at C$.46.